Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Guinea pigs linked to Strep infection
guinea pig
Lab testing indicates the two human cases of Streptococcal infection were linked to guinea pig exposure.
Two patients have developed Streptococcus equi after guinea pig exposure

A new report suggests guinea pigs are a potential source of the serious infection, Streptococcus equi sub species zooepidemicus.

S. zooepidemicus is rarely transmitted from animals to humans. It is most commonly associated with drinking un-pasteurised milk or through contact between infected horses and people with underlying health problems.

However, a recent report published in the Emerging Infectious Disease journal describes the case of two patients who became infected after contact with guinea pigs. Further investigations suggest both patients and two of the three guinea pigs tested were infected with S. zooepidemicus.

Patient one was an adult male from Northern Virginia who arrived in hospital with influenza-like symptoms including worsening bilateral thigh pain and stiffness, shivering, nausea, fatigue, headache and diarrhoea. Blood cultures confirmed group C streptococcal infection and wound cultures identified S. equi.

While a subspecies was not identified, zooepidemicus was suspected as it is the only subspecies of S. equi that is zoonotic.

The second patient was an elderly man from Central Virginia, who is a relative of patient one. He was admitted to hospital a week after patient one and, again, blood cultures confirmed group C Streptococcus spp.

Shortly before being admitted to hospital, patient one had bought four guinea pigs, one of which had died soon after purchase. Patient two had cleaned their enclosure two days prior to his illness.

A relative who was caring for the animals relinquished them to the Virginia Department of Agriculture for euthanasia and testing. Laboratory staff confirmed S. zooepidemicus in isolates collected from two of the three guinea pigs.

In conclusion, researchers say S. zooepidemicus should be considered when a patient has purulent wounds or systemic symptoms of infection, as well as known contact with guinea pigs or their environment. In addition, patients with S. equi should be questioned about their exposure to guinea pigs and other animals.

For the full report visit: http://wwwnc.cdc.gov/eid/article/21/1/14-0640_article

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
Wales licenses Bluetongue vaccines for voluntary use

The Welsh government has approved three Bluetongue vaccines for emergency use in Wales.

From 1 March an online general licence will become available for the vaccines' use. They will then be obtainable on prescription and can be sold by veterinary practices.

After appropriate guidance, livestock keepers will be permitted to administer the vaccines themselves. The vaccines must be prescribed by a veterinary surgeon and detailed vaccination records must be kept for five years.

The decision comes as Bluetongue virus (BTV-3) continues to spread across England. The three vaccines are already licensed for use in England.

Richard Irvine, CVO for Wales, said: "This decision to licence these vaccines was informed by our recent risk assessment indicating that Wales is now at high risk of experiencing an incursion of Bluetongue this year.

"Our primary aim is to keep Bluetongue out of Wales through biosecurity, vigilance and safe sourcing of livestock."